We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Genetic Associations with Coronavirus Susceptibility and Disease Severity

    The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) global public health...
    Fatima Barmania, Juanita Mellet, ... Michael S. Pepper in Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
    Chapter 2023
  2. Association of disease severity and genetic variation during primary Respiratory Syncytial Virus infections

    Background

    Respiratory Syncytial Virus (RSV) disease in young children ranges from mild cold symptoms to severe symptoms that require hospitalization...

    William Bender, Yun Zhang, ... Christopher S. Anderson in BMC Medical Genomics
    Article Open access 19 June 2024
  3. Predicting the Disease Severity of Virus Infection

    The COVID-19 pandemic has resulted in unprecedented burden on global health and economic systems, promoting worldwide efforts to understand, control,...
    **n Qi, Li Shen, ... Bairong Shen in Translational Informatics
    Chapter 2022
  4. Synaptic loss and its association with symptom severity in Parkinson’s disease

    Parkinson’s disease (PD) is the fastest growing neurodegenerative disease, but at present there is no cure, nor any disease-modifying treatments....

    Sophie E. Holmes, Praveen Honhar, ... David Matuskey in npj Parkinson's Disease
    Article Open access 24 February 2024
  5. Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

    Background

    Multimer detection system-oligomeric amyloid-β (MDS-OAβ) is a measure of plasma OAβ, which is associated with Alzheimer’s disease (AD)...

    Sheng-Min Wang, Dong Woo Kang, ... Hyun Kook Lim in Alzheimer's Research & Therapy
    Article Open access 11 March 2024
  6. Accelerated immune ageing is associated with COVID-19 disease severity

    Background

    The striking increase in COVID-19 severity in older adults provides a clear example of immunesenescence, the age-related remodelling of the...

    Janet M. Lord, Tonny Veenith, ... O. Zongo in Immunity & Ageing
    Article Open access 11 January 2024
  7. Association of women-specific health factors in the severity of Parkinson’s disease

    Parkinson’s disease (PD) is an age-related neurological disorder known for the observational differences in its risk, progression, and severity...

    Shilpa C. Rao, Yadi Li, ... Ignacio F. Mata in npj Parkinson's Disease
    Article Open access 05 June 2023
  8. Classification of Parkinson’s disease severity using gait stance signals in a spatiotemporal deep learning classifier

    Abstract

    Parkinson’s disease (PD) is a degenerative nervous system disorder involving motor disturbances. Motor alterations affect the gait according...

    Brenda G. Muñoz-Mata, Guadalupe Dorantes-Méndez, Omar Piña-Ramírez in Medical & Biological Engineering & Computing
    Article 17 June 2024
  9. A nationwide cohort study on diabetes severity and risk of Parkinson disease

    There is growing evidence that patients with type 2 diabetes mellitus (DM) have an increased risk of develo** Parkinson’s disease (PD) and share...

    Kyungdo Han, Bongsung Kim, ... Mee Kyoung Kim in npj Parkinson's Disease
    Article Open access 27 January 2023
  10. Cytokines and lymphocyte subsets are associated with disease severity of severe fever with thrombocytopenia syndrome

    Background

    Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by severe fever with thrombocytopenia syndrome...

    Li Song, Wenlu Zou, ... Lintao Sai in Virology Journal
    Article Open access 03 June 2024
  11. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer’s disease

    Dementia with Lewy bodies (DLB), Parkinson’s disease dementia (PDD), and Parkinson’s disease (PD) collectively known as Lewy body diseases (LBDs) are...

    Lauren Walker, Harry Simpson, ... Johannes Attems in Acta Neuropathologica Communications
    Article Open access 15 February 2024
  12. Smaller Cerebellar Lobule VIIb is Associated with Tremor Severity in Parkinson’s Disease

    Alterations in the cerebellum’s morphology in Parkinson’s disease (PD) point to its pathophysiological involvement in this movement disorder. Such...

    Fatemeh Sadeghi, Monika Pötter-Nerger, ... Simone Zittel in The Cerebellum
    Article Open access 20 February 2023
  13. Plasma metabolites of aromatic amino acids associate with clinical severity and gut microbiota of Parkinson’s disease

    Gut microbial proteolytic metabolism has been reportedly altered in Parkinson’s disease (PD). However, the circulating aromatic amino acids (AAA)...

    Szu-Ju Chen, Yu-Jun Wu, ... Chin-Hsien Lin in npj Parkinson's Disease
    Article Open access 14 December 2023
  14. Severity in the genomic age: the significance of lived experience to understandings of severity

    This article explores the significance of lived experience to understandings of severity in the genomic age. It draws upon data from structured...

    Article Open access 26 June 2024
  15. Horizontal Vestibulo-Ocular Reflex Deficit as a Biomarker for Clinical Disease Onset, Severity, and Progression of Machado-Joseph Disease

    Because of the crucial importance of finding a useful biomarker for further clinical trials in Machado-Joseph disease (MJD), and based on our...

    Zohar Elyoseph, Dario Geisinger, ... Carlos R. Gordon in The Cerebellum
    Article 28 March 2023
  16. Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity

    Background

    Interactions between the gut microbiota, diet, and host metabolism contribute to the development of cardiovascular disease, but a firm link...

    Sajan C. Raju, Antonio Molinaro, ... Marius Trøseid in Genome Medicine
    Article Open access 08 February 2024
  17. Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson’s disease: a randomized controlled clinical trial

    Rationale

    Probiotics have beneficial effects on the nervous system by modulating the gut-brain axis. Additionally, vitamin D supplementation presents...

    Alireza Zali, Shirin Hajyani, ... Bahareh Pakpour in Psychopharmacology
    Article 28 May 2024
  18. Clinical characteristics and factors affecting disease severity in hospitalized tick-borne encephalitis patients in Norway from 2018 to 2022

    Purpose

    To describe the clinical characteristics and factors associated with disease severity in a Norwegian cohort of hospitalized patients with...

    Hilde Skudal, Åslaug Rudjord Lorentzen, ... Hege Kersten in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 27 May 2024
  19. Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination

    Bruton’s tyrosine kinase (BTK) is an emerging target in multiple sclerosis (MS). Alongside its role in B cell receptor signaling and B cell...

    Kirsten Scarlett Evonuk, Sen Wang, ... Suzana Marušić in Acta Neuropathologica Communications
    Article Open access 12 July 2023
  20. Quantitative susceptibility map** from basal ganglia and related structures: correlation with disease severity in progressive supranuclear palsy

    Objective

    We examined whether mean magnetic susceptibility values from deep gray matter structures in patients with progressive supranuclear palsy...

    Syam Krishnan, Sneha Susan George, ... Divya Kalikavil Puthenveedu in Acta Neurologica Belgica
    Article 14 August 2023
Did you find what you were looking for? Share feedback.